Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Joseph Papa
Pharma
Emergent to cut 300 jobs, shutter 2 facilities in major overhaul
Joseph Papa's turnaround plan for the CDMO-turned-biopharma company involves a reduction of 300 jobs and closure of two facilities.
Angus Liu
,
Fraiser Kansteiner
May 1, 2024 5:06pm
Amid turnaround, Emergent BioSolutions names Joseph Papa its CEO
Feb 21, 2024 10:56am
Bausch shed Valeant's name but still leans on price hikes
Aug 16, 2019 10:42am
Are ‘organic’ growth and ‘pivoting’ real at Bausch Health?
Feb 20, 2019 11:33am
Bausch revives FDA quest for psoriasis hopeful Duobrii
Aug 30, 2018 12:00pm
Bausch aims top-seller Xifaxan at new diseases to pump up growth
Aug 10, 2018 10:00am